Cytotoxic T lymphocytes are the body's specialized "killer" cells, precisely eliminating infected or cancerous cells.

Diatron, a STRATEC brand specializing in the development, manufacturing, and marketing of hematology and clinical chemistry ...

The NMPA granted Breakthrough Therapy Designation to sovleplenib for the treatment of wAIHA in March 2026, as a potential new ...

At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...

Whenever there is a wound or infection, the body produces an inflammatory response. This is the body's first line of defense, ...

The U.S. Food and Drug Administration on April 21, 2026, approved Merck’s Idvynso, a once-daily combination pill for HIV ...

TNX-1700 (TFF2-albumin fusion protein) reversed aging-associated gastric inflammation and significantly attenuated tumor progression in aged ...

A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) ...

Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover ...

Therapeutic cancer vaccines have the potential to induce durable and tumor-specific immune responses in addition to the widely used immune checkpoint blockade therapies. These vaccines aim to ...

Version of Record: This is the final version of the article. Here, the authors are proposing a role for miR-196, a microRNA that has been shown to bind and enhance degradation of mRNA targets in the ...